(Q34142424)

English

Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report (English)

1 reference

Europe PubMed Central

31 July 2017

1 reference

based on heuristic

inferred from title

author name string

Adeline Guais

1

1 reference

Europe PubMed Central

31 July 2017

GianFranco Baronzio

2

1 reference

Europe PubMed Central

31 July 2017

Edward Sanders

3

1 reference

Europe PubMed Central

31 July 2017

Frédéric Campion

4

1 reference

Europe PubMed Central

31 July 2017

Carlo Mainini

5

1 reference

Europe PubMed Central

31 July 2017

Giammaria Fiorentini

6

1 reference

Europe PubMed Central

31 July 2017

Francesco Montagnani

7

1 reference

Europe PubMed Central

31 July 2017

Mahsa Behzadi

8

1 reference

Europe PubMed Central

31 July 2017

Laurent Schwartz

9

1 reference

Europe PubMed Central

31 July 2017

Mohammad Abolhassani

10

1 reference

Europe PubMed Central

31 July 2017

publication date

8 October 2010

1 reference

Europe PubMed Central

31 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

31 July 2017

30

1 reference

Europe PubMed Central

31 July 2017

200-211

1 reference

Europe PubMed Central

31 July 2017

1

1 reference

Europe PubMed Central

31 July 2017

https://scigraph.springernature.com/pub.10.1007/s10637-010-9552-x

0 references

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Understanding the Warburg effect: the metabolic requirements of cell proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Tumor cell metabolism: cancer's Achilles' heel

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Why do cancers have high aerobic glycolysis?

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

ATP citrate lyase inhibition can suppress tumor cell growth

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Dichloroacetate induces apoptosis in endometrial cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Metabolic modulation of glioblastoma with dichloroacetate

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Targeting metabolic transformation for cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Why does cytotoxic chemotherapy cure only some cancers?

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Determination of subcutaneous tumor size in athymic (nude) mice

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

ATP-citrate lyase links cellular metabolism to histone acetylation

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Anti-cancer effects of xanthones from pericarps of mangosteen

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Mechanisms of action of DNA-damaging anticancer drugs in treatment of carcinomas: is acute apoptosis an "off-target" effect?

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Biochemical mechanisms of cisplatin cytotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Accumulation of DNA strand breaks and methotrexate cytotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Methotrexate-induced apoptosis is enhanced by altered expression of methylenetetrahydrofolate reductase.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Mechanism of action of taxol

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Inactivation of Bcl-2 by phosphorylation

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Therapy for osteosarcoma: where do we go from here?

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

A phase II pilot trial of 13-cis retinoic acid and interferon-alpha in patients with advanced pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

On the role of transforming growth factor-beta in the growth inhibitory effects of retinoic acid in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Beneficial properties of melatonin in an experimental model of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9552-X

21 January 2018

Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interplay between MYC and HIF in the Warburg effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A tabulated summary of the FDG PET literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic inflammation and pathogenesis of GI and pancreatic cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate for high-grade osteosarcoma in children and young adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in pancreatic adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20931262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-010-9552-X

1 reference

Europe PubMed Central

31 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34142424&oldid=1540771494"